Hologic says FDA cleared more flexible design of MammoSite radiation seeding systemHologic: FDA approves new radiation therapy system BEDFORD, Mass. — Hologic Inc. said the Food and Drug Administration approved a new version of its MammoSite system, which delivers radiation seeds to prevent recurrences of breast cancer. |
|